-
-
-
-
-
-
-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
-
-
-
-
-
-
-
Amgen sales rise, but shares off as investors await obesity data
-
-
-
-
-
-
-
Amgen (AMGN) Completes Acquisition of Horizon Therapeutics
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
-
976,669 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All